Trauma Devices | Market Insights | Asia Pacific (Supplemental) | 2022
Compared to other major orthopedic device markets, the Asia Pacific trauma device market has been somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Nonetheless, the market has been affected by delays to nonurgent trauma cases and use of alternative treatments for less serious cases, hindering procedure volumes to some extent. Beyond the impact of the COVID-19 pandemic, the market will expand moderately, driven by favorable demographics and rising adoption of innovative devices, although pricing pressures—particularly in China, where the regional implementation of volume-based procurement for trauma devices is resulting in ASP declines—will hinder the pace of market revenue growth.
This Medtech 360 Report provides high-level market metrics for trauma devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 11-year period.
